Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Protocol I6T-MC-AMBG (a) A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis - LUCENT 2
Cohn, Steven
(PI)
Internal Medicine
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
5/13/20
→
5/12/25
Funding
Eli Lilly and Company:
$13,125.00
View all
View less